Standard Biotools (LAB) EBITDA Margin Growth (1y) (2011 - 2026)
Standard Biotools (LAB) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 132.07 Bn | 129.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 111.38 Bn | 102.16 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 68.98 Bn | 67.53 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 28.91 Bn | 27.80 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 28.83 Bn | 26.55 Bn | 1.98 Bn | -313.00 |
| 8 | Smith & Nephew | 28.10 Bn | 27.52 Bn | - | - |
| 9 | Koninklijke Philips | 24.30 Bn | 21.26 Bn | 2.01 Bn | 241.00 |
| 10 | Standard Biotools | 302.10 Mn | -153.08 Mn | 11.31 Mn | 7,428.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,428.00 |
| Dec 31, 2025 | 170.00 |
| Sep 30, 2025 | -4,758.00 |
| Jun 30, 2025 | 1,646.00 |
| Mar 31, 2025 | -122.00 |
| Dec 31, 2024 | -2,940.00 |
| Sep 30, 2024 | -3,742.00 |
| Jun 30, 2024 | -7,147.00 |
| Mar 31, 2024 | -6,609.00 |
| Dec 31, 2023 | 226.00 |
| Sep 30, 2023 | 2,972.00 |
| Jun 30, 2023 | 14,230.00 |
| Mar 31, 2023 | 3,771.00 |
| Sep 30, 2022 | -5,231.00 |
| Jun 30, 2022 | -14,804.00 |
| Mar 31, 2022 | -4,486.00 |
| Sep 30, 2021 | -4,717.00 |
| Jun 30, 2021 | -466.00 |
| Mar 31, 2021 | -481.00 |
| Dec 31, 2020 | -959.00 |